Medically reviewed by David Ozeri, MD Complement 3 glomerulopathy (C3G) is a rare kidney disorder—in many cases, the exact cause is unknown.Possible C3G causes include genetic mutations, ...

1 Department of Rheumatology and Immunology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China 2 Department of Critical Care Medicine, Lanxi People’s Hospital, Lanxi, ...

The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...

Graham Taylor has previously received funding from Cancer Research UK, Blood Cancer UK, the UK Medical Research Council, Melanoma UK, and the University of Birmingham to support his research team.

Scientists have found the clearest evidence yet that Epstein-Barr virus (EBV) – which nearly all of us carry for life – is directly responsible for hijacking our immune system's cells to cause lupus, ...

Holly has a degree in Medical Biochemistry from the University of Leicester. Her scientific interests include genomics, personalized medicine, and bioethics.View full profile Holly has a degree in ...

Telitacicept, a new dual inhibitor of the cytokines B-lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand), showed efficacy in adults with active systemic lupus erythematosus (SLE) ...

Complement 3 glomerulopathy (C3G) is a rare kidney disease that affects your body’s innate immune system (complement system). Complement 3 glomerulopathy (C3G) is a kidney disease that’s caused by ...

Elizabeth Rosser receives funding from the Medical Research Foundation, the Lister Institute for Preventive Medicine and the Kennedy Trust for Rheumatology Research. Actress, singer and makeup mogul ...

Singer and actress Selena Gomez recently revealed that she developed arthritis related to her lupus. She has openly discussed her battle with lupus since 2015. While arthritis is often perceived as an ...

Please provide your email address to receive an email when new articles are posted on . Victoria P. Werth, MD, professor of dermatology at the University of Pennsylvania Hospital, and chief of ...

Clinicians managing lupus nephritis should consider persistent isolated C3 as a possible indicator of long-term renal risk. In a post hoc analysis of the BLISS-LN trial, researchers found that ...